Lumos Pharma, Inc.

CIK 1126234 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lumos Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Feb 13, 2025SCHEDULE 13G/A0000769993-25-000155
Feb 13, 2025SCHEDULE 13G/A0001085146-25-001315
Dec 23, 202415-12G0001104659-24-131070
Dec 13, 202440001126234-24-000117
Dec 13, 202440001126234-24-000111
Dec 13, 202440001126234-24-000112
Dec 13, 202440001126234-24-000115
Dec 13, 202440001126234-24-000122
Dec 13, 202440001126234-24-000121
Dec 13, 2024AW0001193125-24-277919
Dec 13, 202440001126234-24-000118
Dec 13, 202440001126234-24-000120
Dec 13, 202440001126234-24-000119
Dec 13, 202440001126234-24-000114
Dec 13, 202440001126234-24-000113
Dec 13, 202440001126234-24-000116
Dec 12, 2024POS AM0001193125-24-276559
Dec 12, 2024S-8 POS0001193125-24-276541
Dec 12, 2024POS AM0001193125-24-276553
Dec 12, 2024POS AM0001193125-24-276551
Dec 12, 2024S-8 POS0001193125-24-276539
Dec 12, 2024EFFECT9999999995-24-003751
Dec 12, 2024S-8 POS0001193125-24-276542
Dec 12, 2024EFFECT9999999995-24-003750
Dec 12, 2024SC TO-T/A0001104659-24-127848